Chromogranin A: its clinical value as marker of neuroendocrine tumours
- 1 June 1998
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 28 (6) , 431-440
- https://doi.org/10.1046/j.1365-2362.1998.00305.x
Abstract
Chromogranin A (CgA) belongs to a family of secretory proteins that are present in dense‐core vesicles of neuroendocrine cells. Owing to its widespread distribution in neuroendocrine tissues, it can ...Keywords
This publication has 73 references indexed in Scilit:
- In vivo imaging of chromogranin A-positive endocrine tumours by three-step monoclonal antibody targetingEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Chromogranin a and Pancreastatin-Like Immunoreactivity in Serum of Gastrinoma PatientsActa Oncologica, 1993
- Serum chromogranin A in the diagnosis and follow‐up of neuroendocrine tumors of the gastroenteropancreatic tractWorld Journal of Surgery, 1992
- Identification of a peptide arising from the specific post‐translation processing of secretogranin IIFEBS Letters, 1991
- Pancreastatin: A novel peptide inhibitor of parietal cell signal transductionBiochemical and Biophysical Research Communications, 1989
- Hormone-Negative, Chromogranin a-Positive Endocrine TumorsNew England Journal of Medicine, 1989
- Chromogranin A: The Primary Structure Deduced from cDNA Clones Reveals the Presence of Pairs of Basic Amino AcidsAnnals of the New York Academy of Sciences, 1987
- Chromogranin A can act as a reversible processing enzyme inhibitorFEBS Letters, 1987
- Secretion of Chromogranin A by Peptide-Producing Endocrine NeoplasmsNew England Journal of Medicine, 1986
- Radioimmunoassay of Chromogranin a in Plasma as a Measure of Exocytotic Sympathoadrenal Activity in Normal Subjects and Patients with PheochromocytomaNew England Journal of Medicine, 1984